Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Cost-effectiveness studies conducted in the UK, Portugal, Canada, and the United States consistently concluded that semaglutide is cost-effective relative to lifestyle management and other pharmacotherapies, including liraglutide ( The present analysis builds on this literature by providing country-specific evidence for Greece, where liraglutide remains the only reimbursed obesity pharmacotherapy and is restricted to adults with morbid obesity and established cardiovascular disease or sleep apnoea
Our weight loss programs are centered around providing our patients foundational education on healthy diets, together with medical interventions including appetite suppressants and supplements to achieve results quickly and safely
Stress may make cravings more noticeable
The 2019 policy directive mandating that comparisons among similar drugs follow pharmacoeconomic principles further solidified the disciplines pivotal role in reimbursement decisions
This helps maintain the safety and effectiveness of the medication for use
US$ 21.13
US$ 29.81
US$ 22.00
US$ 29.59
US$ 29.23
US$ 29.05
US$ 27.68
US$ 23.91
